Combination of vascular endothelial growth factor inhibitors and laser therapy for diabetic macular oedema: a review.

Abstract

This review provides a perspective on published and ongoing clinical trials of vascular endothelial growth factor inhibitors (anti-VEGF agents) combined with laser therapy for diabetic macular oedema (DMO). Although there was little short-term benefit in combining prompt macular laser with anti-VEGF therapy for centre-involving DMO in the Diabetic… (More)
DOI: 10.1111/ceo.12757

Topics

  • Presentations referencing similar topics